← Browse by Condition
Medical Condition

recurrent diffuse hemispheric glioma h3 g34 mutant

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06914479 Phase 1
Recruiting

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Enrollment
11 pts
Location
United States
Sponsor
University of Michigan Rogel C...
View Trial →